![Discovery of ACH-000143: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats | Journal of Medicinal Chemistry Discovery of ACH-000143: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00627/asset/images/large/jm0c00627_0016.jpeg)
Discovery of ACH-000143: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats | Journal of Medicinal Chemistry
![Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection - Venkatramanujam Srinivasan, Daniel P. Cardinali, Uddanapalli S. Srinivasan, Charanjit Kaur, Gregory M. Brown, D. Warren Spence, Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection - Venkatramanujam Srinivasan, Daniel P. Cardinali, Uddanapalli S. Srinivasan, Charanjit Kaur, Gregory M. Brown, D. Warren Spence,](https://journals.sagepub.com/cms/10.1177/1756285611406166/asset/images/large/10.1177_1756285611406166-fig1.jpeg)
Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection - Venkatramanujam Srinivasan, Daniel P. Cardinali, Uddanapalli S. Srinivasan, Charanjit Kaur, Gregory M. Brown, D. Warren Spence,
![Melatonin receptors: molecular pharmacology and signalling in the context of system bias - Cecon - 2018 - British Journal of Pharmacology - Wiley Online Library Melatonin receptors: molecular pharmacology and signalling in the context of system bias - Cecon - 2018 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/71e2e83e-2398-4d8a-b921-4039d4978de7/bph13950-fig-0003-m.jpg)
Melatonin receptors: molecular pharmacology and signalling in the context of system bias - Cecon - 2018 - British Journal of Pharmacology - Wiley Online Library
![Ramelteon molecule. It is melatonin receptor agonist, used to treat insomnia. Molecular model. 3D rendering. Illustration Stock Photo - Alamy Ramelteon molecule. It is melatonin receptor agonist, used to treat insomnia. Molecular model. 3D rendering. Illustration Stock Photo - Alamy](https://c8.alamy.com/comp/2JRC69E/ramelteon-molecule-it-is-melatonin-receptor-agonist-used-to-treat-insomnia-molecular-model-3d-rendering-illustration-2JRC69E.jpg)
Ramelteon molecule. It is melatonin receptor agonist, used to treat insomnia. Molecular model. 3D rendering. Illustration Stock Photo - Alamy
![The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways | Journal of Pharmacology and Experimental Therapeutics The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/306/3/954/F1.large.jpg)
The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways | Journal of Pharmacology and Experimental Therapeutics
![Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials - The Lancet Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials - The Lancet](https://www.thelancet.com/cms/attachment/fdb0a3ab-b0b4-4d87-bd46-c4d5b48f5318/gr1_lrg.gif)
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials - The Lancet
![Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury | Acta Pharmacologica Sinica Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury | Acta Pharmacologica Sinica](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41401-020-0361-2/MediaObjects/41401_2020_361_Fig1_HTML.png)
Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury | Acta Pharmacologica Sinica
![Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6‐Dihydroindolo[2,1‐a]isoquinolines and Related Systems - Tsotinis - 2022 - ChemMedChem - Wiley Online Library Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6‐Dihydroindolo[2,1‐a]isoquinolines and Related Systems - Tsotinis - 2022 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/de95f16c-486a-4300-8bf2-45b81daae747/cmdc202200129-toc-0001-m.jpg)
Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6‐Dihydroindolo[2,1‐a]isoquinolines and Related Systems - Tsotinis - 2022 - ChemMedChem - Wiley Online Library
![Melatonin and their analogs as a potential use in the management of Neuropathic pain - ScienceDirect Melatonin and their analogs as a potential use in the management of Neuropathic pain - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S092966461830264X-gr1.jpg)
Melatonin and their analogs as a potential use in the management of Neuropathic pain - ScienceDirect
![Ramelteon molecule. It is sleep agent, melatonin receptor agonist used to treat insomnia. Molecular model. 3D rendering. Illustration Stock Photo - Alamy Ramelteon molecule. It is sleep agent, melatonin receptor agonist used to treat insomnia. Molecular model. 3D rendering. Illustration Stock Photo - Alamy](https://c8.alamy.com/comp/2JR6WFJ/ramelteon-molecule-it-is-sleep-agent-melatonin-receptor-agonist-used-to-treat-insomnia-molecular-model-3d-rendering-illustration-2JR6WFJ.jpg)